Jensen; Peter Buhl

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jensen; Peter Buhl.The latest application filed is for "methods for treating cancer and predicting drug responsiveness in cancer patients".

Company Profile

1.2.6

Jensen; Peter Buhl - Farum DK
Jensen; Peter Buhl - Copenhagen DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for predicting drug responsiveness in cancer patients Grant 10,835,531 - Knudsen , et al. November 17, 2	2020-11-17
Methods For Treating Cancer And Predicting Drug Responsiveness In Cancer Patients App 20190231795 - KNUDSEN; Steen ; et al.	2019-08-01
Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiation Grant 7,906,515 - Hofland , et al. March 15, 2	2011-03-15
Methods of Treatment Employing Prolonged Continuous Infusion of Belinostat App 20110003777 - Sehested; Maxwell ; et al.	2011-01-06
Cancer Treatment and Cancer Treatment Efficacy Prediction by Blocking and Detecting Protease Inhibitors App 20080019910 - Romer; Maria Unni ; et al.	2008-01-24
Succinimide And Maleimide Derivatives And Their Use As Topoisomerase Ii Catalytic Inhibitors App 20070196360 - Jensen; Peter Buhl ; et al.	2007-08-23
Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation App 20070185124 - Hofland; Kenneth ; et al.	2007-08-09
Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors App 20030032625 - Jensen, Peter Buhl ; et al.	2003-02-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.